Overview Since their approval, the labels for anti-obesity GLP-1s (Zepbound, Wegovy, and Saxenda) have included warnings about the potential risk for suicidal ideation and instruct healthcare providers to monitor patients and discontinue use if they experience suicidal thoughts or behaviors
2018;8: e022768
Well then schedule a consultation with your provider to conduct thorough testing to understand your metabolic health, discuss your weight loss history and goals, and determine whether tirzepatide or another approach best fits your needs
eClinicalMedicine 72 , 102624 (2024)
Depending on the drug, Phase 3 can take one to four years
Contienen el mismo principio activo ( semaglutida , tirzepatida u orforglipron ), pero presentan modificaciones menores, aunque clnicamente importantes, como el uso de una sal distinta, la adicin de excipientes diferentes y la variacin en la concentracin o la dosis del frmaco